14 reports

In addition, Biogen is employing innovative technologies to discover potential treatments for rare and genetic disorders, including new ways of treating diseases through gene therapy in its core and emerging growth areas.

  • Arthritis
  • World
  • Amgen Inc.
  • Antares Pharma, Inc.
  • Bayer AG

ETIOLOGY OF AUTOIMMUNE DISEASES Genetic factors Environmental factor Physical stress, heavy metals, or absorption of organic solvents can lead to autoimmune diseases.

  • Arthritis
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

Under this segment, the company specializes in quality control systems, blood virus testing, toxicology, in vitro and genetic disorder testing, specialty chemistry, molecular pathology, and Internet-based software.

  • Arthritis
  • Market Size
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • SQI Diagnostics Inc.

This agreement enables Regeneron Pharma and Intellia Therapeutics to bring potential cures to patients who are suffering from lifethreatening rare diseases and genetic diseases.

  • Arthritis
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Regeneron Pharmaceuticals, Inc.

ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders.

  • Arthritis
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Galapagos NV

FOP is a rare genetic disorder where the body turns muscle into bone.

  • Arthritis
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • symptomatic knee osteoarthritis. The trial was registered with the U.S National Institutes of Health.
  • OSTEOARTHRITIS PATIENTS. THE TRIAL WAS REGISTERED WITH THE U.S. NATIONAL INSTITUTES OF HEALTH.

Mariel intends to advance clinical trial in osteoarthritis (OA) and for chronic kidney disease (CKD) and Alport' s disease, a genetic kidney fibrosis disease.

  • Arthritis
  • United States
  • Company
  • Product Initiative
  • Can-Fite BioPharma Ltd.
  • OSTEOARTHRITIS PATIENTS. THE TRIAL WAS REGISTERED WITH THE U.S. NATIONAL INSTITUTES OF HEALTH.

Mariel intends to advance clinical trial in osteoarthritis (OA) and for chronic kidney disease (CKD) and Alport' s disease, a genetic kidney fibrosis disease.

  • Arthritis
  • Cell Therapy
  • United States
  • World
  • Product Initiative

APR ##, 2019: SAMUMED DOSES FIRST SUBJECT IN PHASE ## TRIAL OF SM##, A POTENTIAL TREATMENT FOR ALZHEIMER' S DISEASE Samumed, LLC, announced that it has dosed the first subject in its phase ## trial of SM##, a potential treatment for Alzheimer' s

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Samumed, LLC

## Alzheimer' s Disease ## Amyotrophic Lateral Sclerosis ## Chronic Renal Failure ## Coronary Artery Disease ## Depression ## Diabetic Retinopathy ## Duchenne Muscular Dystrophy ## Heart Failure ## Liver Fi

  • Arthritis
  • Diagnostics
  • Mental Health
  • Pathology
  • SomaLogic, Inc.

The company' s therapeutic areas comprise cancer, infectious and autoimmune diseases, allergies, and genetic disorders.

  • Arthritis
  • Neurological Disorder
  • Pathology
  • Therapy
  • Anavex Life Sciences Corp.

CATENA WAS APPROVED TO TREAT DEVASTATING GENETIC DISORDER, FRIEDREICH ATAXIA.

  • Arthritis
  • Cell Therapy
  • Neurological Disorder
  • Pathology
  • Anavex Life Sciences Corp.

Usher Syndrome is a rare genetic disorder that causes the loss of hearing and vision.

  • Arthritis
  • Healthcare
  • Hospital
  • Pharmaceutical
  • BioFocus DPI Limited

Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to Paradowska-Gorycka A, et al. (2010).

  • Arthritis
  • Medical Biotechnology
  • Monoclonal Antibody
  • Protein Therapy
  • Deals & Alliance